Journal of Clinical Medicine (Feb 2023)

Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson’s Disease

  • Diego Santos-García,
  • Ariadna Laguna,
  • Jorge Hernández-Vara,
  • Teresa de Deus Fonticoba,
  • Carlos Cores Bartolomé,
  • Maria J. Feal Painceiras,
  • Maria Cristina Íñiguez-Alvarado,
  • Iago García Díaz,
  • Silvia Jesús,
  • Maria Teresa Boungiorno,
  • Lluís Planellas,
  • Marina Cosgaya,
  • Juan García Caldentey,
  • Nuria Caballol,
  • Ines Legarda,
  • Iria Cabo,
  • Lydia López Manzanares,
  • Isabel González Aramburu,
  • Maria A. Ávila Rivera,
  • Víctor Gómez Mayordomo,
  • Víctor Nogueira,
  • Víctor Puente,
  • Julio Dotor García-Soto,
  • Carmen Borrué,
  • Berta Solano Vila,
  • María Álvarez Sauco,
  • Lydia Vela,
  • Sonia Escalante,
  • Esther Cubo,
  • Francisco Carrillo Padilla,
  • Juan C. Martínez Castrillo,
  • Pilar Sánchez Alonso,
  • Maria G. Alonso Losada,
  • Nuria López Ariztegui,
  • Itziar Gastón,
  • Jaime Kulisevsky,
  • Manuel Menéndez González,
  • Manuel Seijo,
  • Javier Rúiz Martínez,
  • Caridad Valero,
  • Mónica Kurtis,
  • Jessica González Ardura,
  • Ruben Alonso Redondo,
  • Carlos Ordás,
  • Luis M. López Díaz,
  • Darrian McAfee,
  • Pablo Martinez-Martin,
  • Pablo Mir,
  • on behalf of the COPPADIS Study Group

DOI
https://doi.org/10.3390/jcm12041329
Journal volume & issue
Vol. 12, no. 4
p. 1329

Abstract

Read online

Background and objective: Sex plays a role in Parkinson’s disease (PD) mechanisms. We analyzed sex difference manifestations among Spanish patients with PD. Patients and Methods: PD patients who were recruited from the Spanish cohort COPPADIS from January 2016 to November 2017 were included. A cross-sectional and a two-year follow-up analysis were conducted. Univariate analyses and general linear model repeated measure were used. Results: At baseline, data from 681 PD patients (mean age 62.54 ± 8.93) fit the criteria for analysis. Of them, 410 (60.2%) were males and 271 (39.8%) females. There were no differences between the groups in mean age (62.36 ± 8.73 vs. 62.8 ± 9.24; p = 0.297) or in the time from symptoms onset (5.66 ± 4.65 vs. 5.21 ± 4.11; p = 0.259). Symptoms such as depression (p p p p p p p p = 0.002). Perception of quality of life was generally worse in females (PDQ-39, p = 0.002; EUROHIS-QOL8, p = 0.009). After the two-year follow-up, the NMS burden (Non-Motor Symptoms Scale total score) increased more significantly in males (p = 0.012) but the functional capacity (Schwab and England Activities of Daily Living Scale) was more impaired in females (p = 0.001). Conclusion: The present study demonstrates that there are important sex differences in PD. Long-term prospective comparative studies are needed.

Keywords